FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21274411000001104: Ruxolitinib 20mg tablets 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70973901000001110 Ruxolitinib 20mg tablets 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70974001000001113 Ruxolitinib 20mg tablets 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ruxolitinib 20mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has VMP Ruxolitinib 20mg tablets true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has specific active ingredient Ruxolitinib phosphate false Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib false Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has specific active ingredient Ruxolitinib phosphate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Is a True Ruxolitinib 20mg tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start